Assessment of Novel Intraocular Injection Guide

Completed · Not applicable

Conditions studied: Retinal Disease

In brief

To determine if a novel intraocular injection guide (IIG) reduces patient discomfort during and after intravitreal injections.

Key facts

Study ID

NCT02315170

Run by

Maturi, Raj K., M.D., P.C.

People needed

50

Starts

2014-09-01

Expected to finish

2015-01-01

Last updated by the study team

2021-05-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects must be receiving bilateral injections of the same dose of vascular endothelial growth factor (VEGF) inhibitor
• Injections in both eyes must be given on the same day
• Male or female age 18 years or older

You may not qualify if…

• Any condition or reason that precludes the subject's ability to comply with the study -

Where it is running

• Raj K Maturi MD PC — Indianapolis, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.